Company Search:
Advanced Search
Sponsored Links
SAGE Therapeutics Inc Company Snapshot
SAGE Therapeutics Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares SAGE Therapeutics Inc with three other companies in this sector in UNITED STATES : Regulus Therapeutics Incorporated (2019 sales of $6.83 million of which 100% was PHARMACEUTICAL PREPARATIONS), Selecta Biosciences Inc ($6.68 million of which 100% was Pharmaceutical), and Cerecor Inc ($6.75 million of which 100% was clinical-stage pipeline).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
SAGE Therapeutics Inc
  Stock Performance Chart for SAGE Therapeutics Inc
  Stock Data: Recent Stock Performance:
  Current Price (10/23/2020): 71.51
(Figures in U.S. Dollars)
1 Week 3.5%   13 Weeks 17.6%  
4 Weeks 51.2%   52 Weeks -51.1%  
SAGE Therapeutics Inc Key Data:
  Ticker: SAGE Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2019 Sales 6,868,000
(Year Ending Jan 2020).
Employees: 675
  Currency: U.S. Dollars Market Cap: 3,713,870,348
  Fiscal Yr Ends: December Shares Outstanding: 51,934,979
  Share Type: Common Closely Held Shares: 972,805
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.